Radioprotection 61-2 | Page 79

148 C. Michel et al.: Radioprotection 2026, 61( 2), 146 – 155
Table 1. Radionuclides considered in this study: physical half-life, physical or pharmaceutical form, medical application, and administered activity.
Radionuclide
Physical half-life( days) Physical or pharmaceutical form
Medical application
phosphorus-32 14.3
Phosphate
Polycythemia
260 MBq
strontium-89
50.7
chloride( Metastron ®)
Bone metastasis( palliative)
150 MBq
yttrium-90
2.7
Citrate or silicate( colloid) Radiation synovectomy
225 MBq
ibritumomab tiuxetan
Non-Hodgkin lymphoma
1.2 GBq
( Zevalin ®)
SIR-sphere ®
Liver cancers( radioembolization)
2 GBq
( microspheres)
Therasphere ®
( microspheres)
Liver cancers( radioembolization)
5 GBq
indium-111
2.8
Pentetreotide
Tumors overexpressing somatostatin receptors 6.7 GBq
iodine-131
8.0
Iodide
Benign thyroid diseases
700 MBq 800 MBq
Iodide
Thyroid cancer
1.5 GBq 3.7 GBq 5.6 GBq
MIBG
Adrenal cancers( pheochromocytoma, neuroblastoma, etc.)
5.6 GBq 7.4 GBq
Lipiodol( Lipiocis ®)
Liver cancers( radioembolization)
2.2 GBq
samarium-153
1.95
EDTMP
Bone metastasis( palliative)
4 GBq
( Quadramet ®)
holmium-166
1.1
QuiremSpheres ®
Liver cancers( radioembolization)
12 GBq
( microspheres)
erbium-169
9.4
Citrate( colloid)
Radiation synovectomy
750 MBq
lutetium-177
6.7
[ 177Lu ][ DOTA0, Tyr3 ]
Intestine tumours
7.4 GBq
octreotate( Lutathera ®)
PSMA
Metastatic prostate cancers
7.4 GBq
( Pluvicto ®)
rhenium-186
3.8
Citrate( colloid)
Radiation synovectomy
370 MBq
radium-223
11.4
Dichloride
Bone metastasis
6 MBq
( Xofigo ®)
actinium-225
10.0
PSMA-617
Metastatic prostate cancers
15 MBq
Administered activity
Table 2. Equivalent dose rate coefficients for radionuclides in the general case, excluding pure beta emitters or those with maximum beta energy above 1 MeV.
Radionuclide
Equivalent dose rate coefficient( mSv / h / GBq at 1 m)
Reference
indium-111
77
( INRS-IRSN, 2013)
iodine-131
50
( BIR, 1999; European Commission, 1998; Gardin, 2002; CSHPF, 2006)
samarium-153
18
( Parlak et al., 2015)
holmium-166
6.9
( Prince et al., 2014)
lutetium-177:
Lutathera ®
PSMA
8.2 7.1
( Abuqbeitah et al., 2018)( Abuqbeitah et al., 2018)
radium-223
100
( Dauer et al., 2014)
actinium-225
100
( Serencsits et al., 2022)